These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1877476)

  • 1. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group.
    Rossi P; Bolognese L
    Am J Cardiol; 1991 Sep; 68(6):585-92. PubMed ID: 1877476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of thrombolysis versus heparin in unstable angina.
    Schreiber TL; Rizik D; White C; Sharma GV; Cowley M; Macina G; Reddy PS; Kantounis L; Timmis GC; Margulis A
    Circulation; 1992 Nov; 86(5):1407-14. PubMed ID: 1423953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
    Schreiber TL; Macina G; McNulty A; Bunnell P; Kikel M; Miller DH; Devereux RB; Tenney R; Cowley M; Zola B
    Am J Cardiol; 1989 Oct; 64(14):840-4. PubMed ID: 2801550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of segmental kinetics of the left ventricle after intravenous administration of urokinase in the acute phase of myocardial infarction].
    Garnier LF; François G; Charbonnier B; Lang M; Raynaud P; Brochier M
    Ann Cardiol Angeiol (Paris); 1987 Jun; 36(6):313-7. PubMed ID: 3619386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive intracoronary urokinase therapy during percutaneous transluminal coronary angioplasty.
    Schächinger V; Kasper W; Zeiher AM
    Am J Cardiol; 1996 Jun; 77(14):1174-8. PubMed ID: 8651091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intracoronary and intravenous urokinase in acute myocardial infarction.
    Cernigliaro C; Sansa M; Campi A; Bongo AS; Carfora A; Rossi P
    G Ital Cardiol; 1984 Nov; 14(11):927-30. PubMed ID: 6526208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database.
    Volpi A; Cavalli A; Santoro L; Negri E
    Am J Cardiol; 1998 Aug; 82(3):265-71. PubMed ID: 9708651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of high dose intravenous urokinase for acute myocardial infarction.
    Wall TC; Phillips HR; Stack RS; Mantell S; Aronson L; Boswick J; Sigmon K; DiMeo M; Chaplin D; Whitcomb D
    Am J Cardiol; 1990 Jan; 65(3):124-31. PubMed ID: 2296881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto.
    Eur Heart J; 1992 Dec; 13(12):1692-7. PubMed ID: 1289101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment by urokinase of myocardial infarction and threatened infarction. Randomised study of 120 cases].
    Brochier M; Raynaud R; Planiol T; Fauchier JP; Griguer P; Archambaud D; Pellois A; Clisson M
    Arch Mal Coeur Vaiss; 1975 Jun; 68(6):563-9. PubMed ID: 810098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of urokinase in myocardial infarction. A European Collaborative Study.
    Lancet; 1975 Oct; 2(7936):624-6. PubMed ID: 52001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successive ischemic events to a first acute myocardial infarct treated with fibrinolysis. An analysis of GISSI-2 patients considered reperfused by a clinical criterion. Participants in the GISSI-2 study. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Bardelli G; Maggi G; Maggi A; Barlera S
    G Ital Cardiol; 1995 Apr; 25(4):463-72. PubMed ID: 7642053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.
    Wallentin L; Goldstein P; Armstrong PW; Granger CB; Adgey AA; Arntz HR; Bogaerts K; Danays T; Lindahl B; Mäkijärvi M; Verheugt F; Van de Werf F
    Circulation; 2003 Jul; 108(2):135-42. PubMed ID: 12847070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.
    Goldhaber SZ; Hirsch DR; MacDougall RC; Polak JF; Creager MA
    Am Heart J; 1996 Aug; 132(2 Pt 1):314-8. PubMed ID: 8701892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.
    Diefenbach C; Erbel R; Pop T; Mathey D; Schofer J; Hamm C; Ostermann H; Schmitz-Hübner U; Bleifeld W; Meyer J
    Am J Cardiol; 1988 May; 61(13):966-70. PubMed ID: 2452563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of urokinase and heparin on minimal cross-sectional area of the culprit narrowing in unstable angina pectoris.
    Sansa M; Cernigliaro C; Campi A; Simonetti I
    Am J Cardiol; 1991 Aug; 68(5):451-6. PubMed ID: 1872270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.